Det firma, der fremstiller Soliris, vil tilslutte sig de nærmere enkeltheder i en ordning, der i hver EU - medlemsstat skal sikre, at lægemidlet først udleveres, når det er fastslået, at patienten er blevet korrekt vaccineret.
The company that makes Soliris will agree the details of a system in each Member State that will ensure that distribution of the medicine only occurs after checking that the patient has been vaccinated appropriately.